Evidence map›Paper›PMID 25486435›Full record

ArticleOncogene2015

Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability.

E Martín-Villar, B Borda-d'Agua, P Carrasco-Ramirez, J Renart, M Parsons, M Quintanilla, G E Jones

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 79 citations in OpenAlex.

  1. CD8Cancer science · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.International journal of molecular sciences · 2022
    Review
  9. Review
  10. The Role of Podoplanin in Skin Diseases.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Role of RhoC in cancer cell migration.Cancer cell international · 2021
    Review
  14. Article
  15. Frontiers in oncology · 2021
    Article
  16. Review
  17. Review
  18. The Extracellular Matrix in Skin Inflammation and Infection.Frontiers in cell and developmental biology · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

E Martín-VillarInstituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain.
B Borda-d'AguaRandall Division of Cell & Molecular Biophysics, King's College London, London, UK.
P Carrasco-RamirezInstituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain.
J RenartInstituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain.
M ParsonsRandall Division of Cell & Molecular Biophysics, King's College London, London, UK.
M QuintanillaInstituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), Madrid, Spain.
G E JonesRandall Division of Cell & Molecular Biophysics, King's College London, London, UK.
King's College London · GBInstituto de Investigaciones Biomédicas Sols-Morreale · ESUniversidad Autónoma de Madrid · ES

Funding

Cancer Research UK A13651Cancer Research UK A9926Cancer Research UK C7125/A9926Medical Research Council G0401026Medical Research Council G1100041
6 · The paper itself

Abstract

Invadopodia are actin-rich cell membrane projections used by invasive cells to penetrate the basement membrane. Control of invadopodia stability is critical for efficient degradation of the extracellular matrix (ECM); however, the underlying molecular mechanisms remain poorly understood. Here, we uncover a new role for podoplanin, a transmembrane glycoprotein closely associated with malignant progression of squamous cell carcinomas (SCCs), in the regulation of invadopodia-mediated matrix degradation. Podoplanin downregulation in SCC cells impairs invadopodia stability, thereby reducing the efficiency of ECM degradation. We report podoplanin as a novel component of invadopodia-associated adhesion rings, where it clusters prior to matrix degradation. Early podoplanin recruitment to invadopodia is dependent on lipid rafts, whereas ezrin/moesin proteins mediate podoplanin ring assembly. Finally, we demonstrate that podoplanin regulates invadopodia maturation by acting upstream of the ROCK-LIMK-Cofilin pathway through the control of RhoC GTPase activity. Thus, podoplanin has a key role in the regulation of invadopodia function in SCC cells, controlling the initial steps of cancer cell invasion.

Indexed as

Carcinoma, Squamous CellCell Line, TumorCell Surface ExtensionsExtracellular MatrixHumansLim KinasesMembrane GlycoproteinsMembrane MicrodomainsPodoplaninrho-Associated KinasesrhoC GTP-Binding Proteinrho GTP-Binding ProteinsSignal TransductionLIMK1 protein, humanLim KinasesMembrane GlycoproteinsPDPN protein, humanPodoplaninrho-Associated KinasesrhoC GTP-Binding ProteinRHOC protein, humanrho GTP-Binding Proteins

Identifiers

PMID25486435
PMCPMC4430312
OpenAlexW2066445249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.